Civil Unrest in Ferguson Tests St. Louis Area Hospitals
Hospitals in the St. Louis area braced for another violent night Tuesday after at least 25 people were injured in riots triggered by a grand jury's decision not to indict Ferguson, Missouri, police officer Darren Wilson in the fatal shooting of Michael Brown.
Employers Looking to Make Health Plan Changes in 2015
Few employers are planning to eliminate their health benefits in 2015, but they are still looking to make noticeable changes, according to a report from the Employee Benefit Research Institute.
Gene that Could Identify Tamoxifen-Resistant Breast Cancer Discovered
The study, published in PNAS, identified a gene whose expression could be used as a prognostic indicator and could direct treatment in breast cancer patients.
CMS Extends Deadline for Meaningful Use Attestation
The deadline for eligible hospitals and critical access hospitals to attest to meeting meaningful use requirements has been pushed back a full month, according to CMS.
Restricted Specialty Drug Distribution Could Raise Cancer Drug Costs
Genentech's decision to use a handful of specialty drug distributors instead of wholesalers for the distribution of the most commonly used anticancer medications has raised concerns of availability and cost.
Caloric Information Needed in Chain Restaurants and Vending Machines: FDA
The rule applies to restaurants, retail food establishments, and vending machines with 20 or more locations.
Study Strengthens Link Between Obesity and Prostate Cancer
The large retrospective study, conducted in 9.8 million men, identified a strong association between obesity and the development of an advanced and more aggressive form of the disease.
AJMC Article Explores Reducing the Confusion Between Branded and Generic Drugs
A commentary in this month’s issue of The American Journal of Managed Care explores whether allowing generic versions of medications to look like branded equivalents would be better for consumers and improve adherence.
HHS Proposes Fixed Open Enrollment Dates, Automatic Re-Enrollment Alternatives
In the first 2 years of the Affordable Care Act, open enrollment has run for 2 different time periods, and HHS is looking to set a fixed date for future years. Plus, it offers a solution to automatic re-enrollment.
Amgen's Rilotumumab Fails...Again
The monoclonal antibody,a c-Met inhibitor, was being tested in advanced gastric cancer patients following it's revival 2 years back.
FDA Update on the Use of Power Morcellators
In the update, the FDA is now asking the device manufacturers to include a black box warning and contraindications, to warn both providers and patients of possible health risks with the procedure.
The Road to Extinction: Oncology Private Practice
This article in The New York Times details the reasons why private oncology practices are being forced to consolidate to stay afloat.
Seeking the Right to Try
Laws allowing terminal patients to try drugs not approved by the FDA have passed in five states, but experts question their efficacy.
Northwestern Study Discovers Treatment For Pediatric Gliomas
The study, published in Nature Medicine, identified a small molecule inhibitor that increases histone methylation, compensating for the reduced methylation caused by mutation in the H3F3A gene, resulting in gliomas.
Officials Revise Goals on Containing Ebola After Signs of Wider Exposure in Mali
The leaders of the United Nations and the World Health Organization expressed renewed alarm on Friday about Ebola’s tenacity in Africa and, in particular, its potential to ravage a fourth country, Mali, where they said hundreds of people had been exposed to an infected cleric who died last month.
Using EHRs to Find Hidden Drug Benefits
Researchers at Vanderbilt University Medical Center have used electronic health record analysis to uncover hidden drug benefits, according to a study appearing in the Journal of the American Medical Informatics Association.
The Extended "Fix" for Canceled Health Insurance Policies: Latest State Action
In March, the Obama administration released guidance extending the renewal of health insurance policies that do not meet the Affordable Care Act’s coverage standards through October 1, 2016. At least 9 states that did not adopt the administration’s original transitional policy are now allowing renewals of noncompliant policies after January 1, 2014.
How to Arrive at the Best Health Policies
Randomized trials are highly effective for suggesting ways to improve healthcare delivery, but they’re also rare. That may be changing.
With Third Lawyer, Republicans File Lawsuit Over the ACA
Republicans finally filed a lawsuit against President Obama’s healthcare reform law, the Affordable Care Act, after approving the suit in July. They are challenging the employer-based coverage aspect of the law, as well as Treasury payments to insurers.
Active Surveillance Might Work for Most With Prostate Cancer
A recent study published in European Urology highlights quality-of-life benefits with active surveillance in men with prostate cancer.
Generic Drug Price Escalation Debate Reaches the Senate
Vermont Senator Bernie Sanders has introduced a bill that would require generic drugmakers to pay rebates to the federal Medicare and Medicaid programs when prices of their medications outpace inflation.
Salk Scientists Want to Target the Protein Interactome for Drug Discovery
The study, published in Cell Reports, evaluates the dynamic protein interactions that promote different diseases including cancer. By capturing these interactions, the authors hope to discover new drug targets.
French Government Negotiates a Deal With Gilead for Sovaldi
Being promised a 100% reimbursement, Gilead will now make the drug available to HCV patients in France at 60% of the cost in the United States.
Large National Study Identifies Mastectomy Trend in Early Stage Disease
The retrospective study, published in JAMA Surgery, could not necessarily point to the underlying reason for this treatment choice.
IMS Report Estimates Over A Trillion Dollars in Drug Spending This Year
According to the report, sofosbuvir for hepatitis C infections and new cancer drugs were the drivers of the high spending costs, a 7% jump over the previous year.